Gain-framed Messages and NRT for Lung Cancer Screening Patients
Status: | Recruiting |
---|---|
Conditions: | Lung Cancer, Smoking Cessation |
Therapuetic Areas: | Oncology, Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | 55 - Any |
Updated: | 8/4/2018 |
Start Date: | July 1, 2017 |
End Date: | January 2021 |
Contact: | Benjamin Toll, PhD |
Email: | toll@musc.edu |
Phone: | 843-876-1132 |
Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs
This research is a randomized smoking cessation trial conducted within and specifically
personalized for lung cancer screening patients presenting to a lung screening clinic. Novel
tobacco treatments for this population are critically needed, given the growing population of
lung screening patients, which will grow dramatically now that lung screening is an approved
CMS benefit. In the proposed study, we will test a gain-framed messaging intervention
specifically designed for lung screening patients (vs. unframed messaging), as well as
evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be
translational (in that it can be transferable from our controlled efficacy study to other
lung screening programs).
personalized for lung cancer screening patients presenting to a lung screening clinic. Novel
tobacco treatments for this population are critically needed, given the growing population of
lung screening patients, which will grow dramatically now that lung screening is an approved
CMS benefit. In the proposed study, we will test a gain-framed messaging intervention
specifically designed for lung screening patients (vs. unframed messaging), as well as
evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be
translational (in that it can be transferable from our controlled efficacy study to other
lung screening programs).
Inclusion Criteria:
1. 55 years or older
2. 30 pack year history of smoking
3. current smoker (defined as any smoking in the past 30 days)
4. willing to be randomized
5. English speaking
Exclusion Criteria:
1. unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis,
severe alcohol dependence, or dementia,
2. known allergy to adhesives
3. being in the immediate (within 2 weeks) post myocardial infarction period
4. serious arrhythmias
5. unstable angina pectoris
6. hemodynamically or electrically unstable.
We found this trial at
2
sites
171 Ashley Avenue
Charleston, South Carolina 29425
Charleston, South Carolina 29425
843-792-1414
![Medical University of South Carolina](/wp-content/uploads/logos/medical-university-of-south-carolina.jpg)
Principal Investigator: Benjamin Toll, PhD
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
333 Cedar Street
New Haven, Connecticut 06520
New Haven, Connecticut 06520
(203) 785-4095
![Yale Cancer Center](/wp-content/uploads/logos/yale-cancer-center.png)
Principal Investigator: Lisa Fucito, PhD
Yale Cancer Center Yale Cancer Center combines a tradition of innovative cancer treatment and quality...
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)